Transgene is a biotechnology company that designs and develops targeted immunotherapies for the treatment of cancer and infectious diseases. The company's lead product candidate, TG4010, is a therapeutic vaccine designed to treat non-small cell lung cancer. Transgene's immunotherapy platform is based on the use of viral vectors to deliver therapeutic genes directly into cells. The company was founded in 1979 and is headquartered in Strasbourg, France.